Natural Cycles: Revolutionizing Women's Health
May 30, 2024, 9:34 am
Natural Cycles, the innovative fertility tracking app turned contraceptive, recently secured a whopping $55 million in funding, paving the way for a potential IPO in the near future. Founded by physicist couple Raoul and Elina Berglund Scherwitzl in 2013, Natural Cycles has been making waves in the women's health industry with its unique approach to birth control.
The app, which uses data such as temperature, menstruation regularity, and sperm survival rates to suggest optimal days for sex to avoid pregnancy, has garnered regulatory clearance from the FDA as a contraceptive - a feat no other fertility tracker has achieved. With over three million users worldwide, Natural Cycles has proven to be a game-changer in the realm of women's health.
The recent funding round, led by Lauxera Capital Partners, will fuel the company's expansion into new product areas such as menopause and other aspects of women's health. CEO Raoul Scherwitzl envisions an IPO on the horizon, signaling the company's growth and potential for further innovation.
In addition to its contraceptive capabilities, Natural Cycles has introduced new features like NC° Postpartum, aimed at supporting new mothers through the physical and mental challenges of childbirth. This holistic approach to women's health sets Natural Cycles apart from traditional birth control methods, offering a hormone-free alternative with a focus on user support and empowerment.
With a strong emphasis on user privacy and data security, Natural Cycles is committed to complying with the strictest privacy policies across different regions. This dedication to safeguarding user information sets the company apart in an era where privacy concerns surrounding health data are on the rise.
As the women's health landscape continues to evolve, Natural Cycles stands out as a beacon of innovation and empowerment for individuals seeking a modern approach to contraception. With a clear vision for the future and a track record of success, Natural Cycles is poised to revolutionize women's health and redefine the way we think about birth control.
The app, which uses data such as temperature, menstruation regularity, and sperm survival rates to suggest optimal days for sex to avoid pregnancy, has garnered regulatory clearance from the FDA as a contraceptive - a feat no other fertility tracker has achieved. With over three million users worldwide, Natural Cycles has proven to be a game-changer in the realm of women's health.
The recent funding round, led by Lauxera Capital Partners, will fuel the company's expansion into new product areas such as menopause and other aspects of women's health. CEO Raoul Scherwitzl envisions an IPO on the horizon, signaling the company's growth and potential for further innovation.
In addition to its contraceptive capabilities, Natural Cycles has introduced new features like NC° Postpartum, aimed at supporting new mothers through the physical and mental challenges of childbirth. This holistic approach to women's health sets Natural Cycles apart from traditional birth control methods, offering a hormone-free alternative with a focus on user support and empowerment.
With a strong emphasis on user privacy and data security, Natural Cycles is committed to complying with the strictest privacy policies across different regions. This dedication to safeguarding user information sets the company apart in an era where privacy concerns surrounding health data are on the rise.
As the women's health landscape continues to evolve, Natural Cycles stands out as a beacon of innovation and empowerment for individuals seeking a modern approach to contraception. With a clear vision for the future and a track record of success, Natural Cycles is poised to revolutionize women's health and redefine the way we think about birth control.